Brian Ngongheh Ajong

Brian Ngongheh Ajong

Auto-generated profile, based on publicly available information

Brian Ngongheh Ajong

Democratic Republic of the Congo Country Office World Health Organization, Kinshasa, Democratic Republic of the Congo

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2026 in Evidence Synthesis in Healthcare Connect
Verified
Journal Article
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
WBWilliam Ndjidda Bakari
William Ndjidda Bakari
CAChabeja Achangwa
Chabeja Achangwa
JGJessy Goupeyou-Youmsi
Jessy Goupeyou-Youmsi
JNJonathan Hangi Ndungo
Jonathan Hangi Ndungo
Introduction: Monkeypox (Mpox) is an endemic disease in the Democratic Republic of Congo (DRC). After five decades of outbreaks, gaps still remain in understanding clinical patterns and coinfections with varicella-zoster virus (VZV) and human immunodeficiency virus (HIV) in this high-burden setting. This systematic review and meta-analysis were conducted to synthesize data on Mpox clinical presentation and coinfection trends in the Democratic Republic of the Congo. Estimating the burden of VZV and HIV coinfections will help informing decision maker during the fight against this outbreak. Methods: This study was conducted by systematically extracting data from online databases including PubMed, ScienceDirect, and Google Scholar. The pooled estimate VZV and HIV coinfection rates were calculated using fixed and random-effects models. Subgroup analyses were performed by time period, region, study design, setting, and participant characteristics. Results Among a total of 1,841 confirmed Mpox cases, VZV coinfection was 9.69% (95% CI: 1.33–18.06; n = 8), with higher rates in Kivu (33.33%) compared to Equateur (11.10%). The VZV pooled prevalence rate among 64,131 suspected Mpox cases was 16.73% (95% CI: 5.36-28.10; n = 8), with I2 = 99.4% (p ˂ 0.001). The pooled estimate of HIV coinfection rate was low (0.52%, 95% CI: 0.18–0.87) at national level but elevated in South Kivu (1.64%). Among confirmed cases, rash (99.97%), painful lesions (78.17%), and Malaise (77.14%) were the main clinical presentation and this highlights their diagnostic importance in the case definition. A similar clinical pattern of Mpox was observed among suspected cases, were almost all recorded cases reported rash (99.43%) and fever (98.91%). Heterogeneity was high (I² > 90%) for most study outcomes. Conclusion: The substantial VZV coinfection prevalence and distinct regional HIV patterns highlight critical gaps in syndromic surveillance and the urgent need for integrated diagnostic strategies. This review confirms that Mpox in the DRC presents with near-universal rash, underlining their centrality to case definitions. These findings provide essential evidence for strengthening frontline detection and tailored outbreak response in endemic zones.

5 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
WBWilliam Ndjidda Bakari
William Ndjidda Bakari
CAChabeja Achangwa
Chabeja Achangwa
JGJessy Goupeyou-Youmsi
Jessy Goupeyou-Youmsi
SNSaralees Nadarajah
Saralees Nadarajah
Background: Monkeypox (Mpox) remains endemic in the Democratic Republic of Congo (DRC), with inc. Despite five decades of outbreaks, gaps persist in understanding clinical patterns and coinfections with varicella-zoster virus (VZV) and HIV in this high-burden setting. Methods: We conducted a systematic review and meta-analysis (1970–2024) of Mpox cases in the DRC, extracting data from PubMed, ScienceDirect, and Google Scholar. Pooled prevalence rates were calculated using fixed and random-effects models, with subgroup analyses by time period, region, setting, study design and participant characteristics. Results: Among 1,841 confirmed Mpox cases, VZV coinfection was 9.69% (95% CI: 1.33–18.06; n = 8), with higher rates in Kivu (33.33%) versus Equateur (11.10%). The VZV pooled prevalence rate among 64131 suspected Mpox cases was 16.73% (95% CI: 5.36-28.10; n = 8), with I 2 = 99.4% ( p □ 0.001). HIV coinfection was low (0.52%, 95% CI: 0.18–0.87) but elevated in South Kivu (1.64%). Among confirmed cases, rash (99.97%), painful lesions (78.17%), and Malaise (77.14%) dominated clinical presentation and underscored their diagnostic importance in the case definition. A similar clinical pattern of Mpox was observed among suspected cases, featuring a near-universal presentation of rash (99.43%) and fever (98.91%). Heterogeneity was high ( I 2 > 90% ) for most outcomes. Conclusion: Mpox in the DRC presents with consistent rash-centered symptomatology but high VZV coinfection rates complicate diagnosis. The low HIV coinfection suggests distinct transmission dynamics from global outbreaks. Findings underscore the need for integrated VZV/Mpox diagnostics and context-specific surveillance in endemic regions.

23 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
SDSolange Dabou
Solange Dabou
BABrian Ngongheh Ajong
Brian Ngongheh Ajong
GNGuy Stéphane Nloga
Guy Stéphane Nloga
TITakougang Innocent
Takougang Innocent
Background Emergency medicine systems are vital for reducing mortality and disability, yet Cameroon faces significant healthcare access challenges, with only 0.6% of GDP allocated to public health and 70% of health expenditures paid out-of-pocket. This study assessed proportion of population benefiting from health coverage, patterns, and associated factors in Cameroon to inform policies aimed at achieving universal health coverage (UHC). Methods A nationally representative cross-sectional survey was conducted from February to March 2024, involving 1,200 adults selected via multistage random sampling. Data were collected through face-to-face interviews by national Afrobarometer team, and analyzed with R Statistics version 4.4.2. Logistic regression identified factors associated with medical coverage, adjusting for sociodemographic, economic, and occupational variables. Results A proportion of 7.9% (95% CI: 6.4–9.6) of respondents reported benefiting from a health coverage in 2024, with the lowest rates reported in the North, Adamawa, Centre, and North-West regions. Private health insurance was the most common (44.3%), followed by civil servant schemes (20.5%) and community-based insurance (15.9%). Unemployed individuals were twice as likely to lack coverage (aOR = 2.22, 95% CI: 1.42–3.51). Those with secondary education had twice the odds of being uninsured compared to tertiary-educated individuals (aOR = 2.00, 95% CI: 1.21–3.27). Insured individuals were more likely to use healthcare services (9.6%; p = 0.028), reported easier access to medical care (15.8%; p = 0.010), and expressed fewer concerns about healthcare access (23.4%; p < 0.001). Barriers among the uninsured included high costs (37.1%), lack of information (31.6%), complex registration processes (8.5%) and geographical constraints. Most of the community members reported being quite (51.1%) or very satisfied (23.9%) by the medical coverage they are benefiting from. Notably, 68% of respondents supported higher taxes to improve healthcare access. Conclusion Cameroon’s suboptimal medical coverage reflects systemic inequities tied to employment and education. Expanding employer-independent schemes, subsidizing premiums, and leveraging community-based models are critical to advancing UHC. Public willingness to contribute through taxes suggests political viability for systemic reforms.

1 January 2021 in Fortune Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
ANAjong Brian Ngongheh
Ajong Brian Ngongheh
ADAkateh Derek
Akateh Derek
AAAgbornkwaiNyenty Agbor
AgbornkwaiNyenty Agbor
COCalvin Besong Eta Oben
Calvin Besong Eta Oben
TATambe Elvis Akem
Tambe Elvis Akem
LELongsti Scarlet Tabot Enanga
Longsti Scarlet Tabot Enanga
Background: Anaemia in pregnancy is a risk factor for maternal and neonatal morbidity and mortality. Interventions to reduce its burden start from the first antenatal visit and continue throughout pregnancy. Previous studies report that anaemia in pregnancy is a public health concern as early as the first antenatal visit. This study sought to measure the prevalence and identify risk factors of anaemia among pregnant women attending their first antenatal visit. Methods: A cross-sectional study was conducted at Buea Regional Hospital. Questionnaires were administered to collect socio-demographic data and risk factors of anaemia in pregnancy. Blood was used to measure haemoglobin concentration, malaria parasitaemia and HIV serology. Risk factors for anaemia in pregnancy were identified using univariable and multivariable analysis in logistic regression. P–values <0.05 were considered statistically significant. Results: Among 250 pregnant women, 171 (68.4%) were anaemic. In multivariable analysis, malaria infection and gravidity were significantly associated with anaemia in pregnancy (AOR=9.47, p<0.001 and AOR=1.98, p=0.044respectively). There was a strong negative correlation between malaria parasitaemia and haemoglobin concentration (r= -0.5816, p<0.001). Early anti-malaria therapy during the current pregnancy was associated with a lower risk of anaemia in pregnancy among primigravida (AOR=0.378, p=0.013). Conclusions: High prevalence of anaemia in pregnancy in this study demonstrates its public health importance in the first antenatal visit. Malaria infection and parity are strong modifiable and non-modifiable risk factors respectively. Prompt anti-malaria therapy in primigravida is critical in reducing anaemia in pregnancy.

6 December 2024 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
CMChristian Mouangue
Christian Mouangue
BABrian Ngongheh Ajong
Brian Ngongheh Ajong
MEMichel Franck EDZAMBA
Michel Franck EDZAMBA
DHDilane Christian Maidey Hamadama
Dilane Christian Maidey Hamadama
AAAdidja AMANI
Adidja AMANI
Background: Occupational exposure to blood and body fluids has become a serious public health problem for healthcare workers and is a major risk for the transmission of bloodborne infections such as human immune-deficiency, hepatitis B, and hepatitis C viruses. It has been identified as one of the most serious issues affecting the health and well-being of health workers in most health systems especially in developing countries. The present systematic review and meta-analysis was conducted to estimate the pooled prevalence of blood and other body fluids exposures among healthcare workers in Cameroon. Methods: Online platform including PubMed, Google Scholar, Cochrane Library, and Science Direct were systematically searched to collect relevant research reports. Unpublished studies in a national library were also consulted. The I 2 tests were used to assess the heterogeneity of the included studies. A fixed and random-effects meta-analysis model was used to estimate the lifetime and 12-month prevalence of occupational exposure to blood and other body fluids among healthcare workers in Cameroon. Results: Of the 539 records identified through the database search, 15 study reports were included in the final analysis. The random-effects model showed that the estimated overall pooled prevalence of 12-month and lifetime exposure to blood and other body fluids among healthcare workers in Cameroon was 55.44% (95% Confidence Interval (CI): 41.20-69.68); ( I 2 =97.5%; p <0.001) and 57.27% (95% CI: 42.43-72.10); ( I 2 =97.7%; p <0.001) respectively. The highest 12-month pooled prevalence was observed in intermediate level health facilities (84.73%; 95% CI: 85.55-88.50), in Regions other than the Centre (70.87%; 95% CI: 37.26-95.13) and for studies conducted from 2017 to 2023 (65.63%; 95% CI: 45.73-83.06). The lifetime prevalence of blood and other body fluids exposures was the highest for Regions namely the North-west and South-west Regions (77.96%; 95% CI: 57.39-93.19). Conclusion: Healthcare workers in Cameroon face a significant risk of occupational exposure to blood and body fluids (BBFs), with a high prevalence of exposure over their lifetime and in the past 12 months. This highlights the urgent need to enhance and implement effective occupational safety and health policies to protect healthcare workers in Cameroon.

15 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
AAAdidja AMANI
Adidja AMANI
BABrian Ngongheh Ajong
Brian Ngongheh Ajong
LBLionel Berthold Keubou Boukeng
Lionel Berthold Keubou Boukeng
CMChristian Mouangue
Christian Mouangue
FNFlorence Kissougle Nkongo
Florence Kissougle Nkongo
Background: Integrating the principles of humanized care into healthcare systems is critical to promoting optimal well-being throughout the patient care process. In a context of limited resources, improving the quality of care and health services means identifying priority sites to optimize cost-effectiveness. The objective was to measure key indicators of quality and safety of care in health facilities (HFs) and to map priority health districts (HDs) for effective implementation of high-impact interventions in the Centre Region. Methods: We conducted a descriptive cross-sectional analysis using retrospective data from 2018 to 2022 from 32 HDs comprising the Centre Region were extracted in April 2023. Data were retrieved from the national database using DHIS 2 and checked for completeness. The health indicators assessed were those defined in the Cameroon Health Sector Strategy for 2020-2030. Results: The density of the qualified HCWs was 13.7 per 10 000 inhabitants in 2022. The density of doctors in rural areas has fallen sharply over the five-year study period, with a decline of almost 20% by 2020 in favor of urban areas. The Odza HD had the highest inpatient mortality rate over the five-year study period (49%). In rural areas, the Esse HD had the highest mortality rate (32.4%). Esse (18.8%) and Odza (6.7%) HDs had the highest perioperative mortality rates in rural and urban areas, respectively. Most of the urban HDs (5/8=62.5%) had a neonatal mortality rate higher than the regional median (RM=3.1). Half of the rural HDs had a maternal mortality ratio higher than the regional median (RM=118 per 1000 live births). The HDs of Mbandjock (357/1,000) and Mvog-Ada (285/1,000) were the most affected in rural and urban areas respectively. More than two thirds of urban HDs recorded a proportion of free malaria treatment cases below the regional median (14%). Conclusions: Efforts to humanize healthcare in the Centre Region are hindered by persistent disparities in care quality and inconsistent policy implementation. Addressing these challenges requires timely implementation of a National Strategic Plan to Improve the Quality of Healthcare and Service Delivery, emphasizing on capacity building through training and supervision.